CYTOCARE 532

CYTOCARE 532 is an implant developed by Laboratories Revitacare, a French pharmaceutical company that specializes in cosmetology and aesthetic medicine. It effectively corrects the aging process of the skin while minimizing the appearance of wrinkles and fine lines. In addition, CYTOCARE 532 helps restore the skin’s elasticity, tonicity and moisture level.

CE-certification: CYTOCARE 532 is fully CE-certified.
Higher hydrating capacity: Thanks to the CT50 complex it contains, CYTOCARE 532 has the best hydrating capacity in vivo, outperforming other hyaluronic acid-based dermal fillers.

10 prefilled 5ml syringes
20 traceability labels
1 package insert

CYTOCARE 532 helps densify the skin through the on-surface action of keratinocytes and in-depth action of fibroblasts. Plus, it improves skin vitality while protecting the skin from the harmful effects of oxidizing agents.

Rejuvenating complex CT 50
Hyaluronic acid (32 mg)
Buffered preservation media

Results of CYTOCARE 532 typically last for months. Please note that actual results may vary among patients depending on their skin type and age.

Cytocare treatment does not usually cause significant downtime.

If your patient has a streptococcal illness, perform a double test prior to using CYTOCARE 532. It is not advisable to use CYTOCARE 532 in patients with rheumatic fever.
You must not use CYTOCARE 532 in patients who have a skin condition (or alteration), or those with known hypersensitivity to one of the ingredients of the formulation. The use of CYTOCARE 532 is contraindicated in these patients.
Avoid mixing CYTOCARE 532 with other products. Be aware that hyaluronic acid (one of the key components of the formulation) is incompatible with benzalkonium chloride or other quaternary ammonium salts.

Slight local inflammation
Edema
Tingling
Small hematomas
Redness